|
Case | Age/gender | Disease | Onset after sunitinib | Sunitinib dose (mg) | Blood pressure (mmHg) | Management | Clinical outcome of RPLS |
|
1 [3] | 54/F | GIST | 8 months | 50 | 210/110 | Sunitinib discontinuation antihypertensive drug anticonvulsant | Complete recovery in 10 days |
2 [3] | 70/F | RCC | 2 weeks | 50 | 170/100 | Complete discontinuation antihypertensive drug anticonvulsant | Complete recovery in a few days |
3 [3] | 81/F | RCC | 5 months | ā | 130/74 | Sunitinib discontinuation | Complete recovery in 1 month |
4 [4] | 84/F | RCC | 2 weeks | 50 | 142/72 | Sunitinib discontinuation | Complete recovery in 3 days |
5 [3] | 39/F | RCC | 1 week | ā | 160/102 | Sunitinib discontinuation antihypertensive drug anticonvulsant | Complete recovery in 2 weeks |
6 [3] | 48/F | RCC | 1 week | 50 | 190/130 | Sunitinib discontinuation | Complete recovery in 3 weeks |
7 [3] | 65/M | RCC | 8 days | 50 | 160/100 | Sunitinib discontinuation antihypertensive drug | Complete recovery in 17 days |
8 [5] | 61/M | RCC | 15 weeks | 50 | 202/101 | Sunitinib discontinuation antihypertensive drug anticonvulsant | Complete recovery in 10 weeks |
9 [6] | 48/F | RCC | 3 months | 50 | 178/117 | Sunitinib discontinuation antihypertensive drug anticonvulsant | Complete recovery in 8 weeks |
10 [7] | 71/F | RCC | 8 months | 37.5 | 179/110 | Sunitinib discontinuation antihypertensive drug anticonvulsant | Complete recovery in 3 days |
11 [8] | 67/M | RCC | 2 months | 50 | 180/100 | Sunitinib discontinuation antihypertensive drug anticonvulsant | Complete recovery not achieved (cancer death in a few weeks) |
Present case | 64/M | RCC | 2 years (5 months from reinitiation) | 50 | 230/129 | Sunitinib discontinuation antihypertensive drug anticonvulsant | Complete recovery in 3 weeks |
|